CMPX icon

Compass Therapeutics
CMPX

Overview Fund Activity

103 hedge funds and large institutions have $281M invested in Compass Therapeutics in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 41 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
-4
Holders Change %
-3.74%
% of All Funds
1.38%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
24
Reduced
41
Closed
24
Calls
$85K
Puts
$6.54M
Net Calls
-$6.45M
Net Calls Change
-$4.53M

Top Buyers

1
SCM
1
Suvretta Capital Management
New York
$18.6M
2
VC
2
Vivo Capital
California
$15.7M
3
TCM
3
Tang Capital Management
California
$35.1M
4
CM
4
Caption Management
Oklahoma
$1.89M
5
DCM
5
DAFNA Capital Management
California
$1.37M

Top Sellers

1
O
1
OrbiMed
New York
$39.6M
2
MB
2
MPM BioImpact
Massachusetts
$14.6M
3
BlackRock
3
BlackRock
New York
$16.7M
4
Morgan Stanley
4
Morgan Stanley
New York
$647K
5
SG Americas Securities
5
SG Americas Securities
New York
$969K
Name Holding Trade Value Shares
Change 		Shares
Change %
TWD
126
True Wealth Design
Ohio
– -$38 -20 Closed
IA
127
IFP Advisors
Florida
– -$30 -16 Closed
2 3 4 5
6